Fig. 3 | Scientific Reports

Fig. 3

From: Interrogating ABCC1 and CASP1 as key players in epigallocatechin gallate’s action against radiotherapy-resistant nasopharyngeal carcinoma

Fig. 3

Identification and validation of the prognostic signature. (A) Univariate Cox regression analysis identifying 2 prognostic targets. (B) LASSO analysis. (C) Heatmap of the signature genes correlated with risk-score. (D) Risk score distribution and survival status of NPC samples based on the risk score. (E) Kaplan-Meier curves of survival between patients in the high- and low-risk group. (F) Time-dependent ROC curves of 1-, 2-, and 3-years of NPC patients.

Back to article page